comparemela.com

Latest Breaking News On - Clear cell renal carcinoma - Page 1 : comparemela.com

New PET Agent Enables Same-Day Imaging for Kidney Cancer

New PET Agent Enables Same-Day Imaging for Kidney Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia
Tennessee
United-states
Memorial-sloan-kettering-cancer-center
New-york
Switzerland
Melbourne
Victoria
Jonathan-wessen
Ivana-galetic
Solen-pichereau
Olena-vlasyuk

New PET agent provides same-day imaging for clear cell renal cell carcinoma patients

New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Australia
Melbourne
Victoria
Michaels-hofman
Michael-hofman
Peter-maccallum-cancer-centre
Journal-of-nuclear-medicine
Nuclear-medicine
Provides-exceptional-same-day-imaging
Clear-cell-renal-carcinoma-patients
Professor-michael-hofman
First-in-human-safety

Dr Srour on the Safety and Efficacy of the Allogeneic CAR T-Cell Therapy CTX130 in Advanced ccRCC

Samer A. Srour, MB ChB, MS, discusses efficacy and safety data for the allogeneic CAR T-cell therapy CTX130 in advanced clear cell renal cell carcinoma.

Texas
United-states
Samera-srour
University-of-texas-md-anderson-cancer-center
Department-of-stem-cell-transplantation
Division-of-cancer-medicine
Stem-cell-transplantation
Cancer-medicine
Cancer-center
B-chb
Us

First-Line Treatments for Advanced Clear Cell RCC

A panel of medical oncologists who specialize in renal cell carcinoma (RCC) introduce themselves and discuss the first-line treatment landscape and risk stratification of clear cell RCC.

Advanced-renal-cell-carcinoma
Line-treatments
Advanced-clear-cell
Renal-cell-carcinoma
Nrcc
Advanced-rcc
Clear-cell-renal-carcinoma
Non-clear-cell-renal-carcinoma
Immunotherapy
Ipilimumab
Nivolumab

Subcutaneous Nivolumab Provides Clinical Equipoise to Standard IV Dosing in ccRCC

Subcutaneous nivolumab coformulated with rHuPH20 demonstrated noninferiority of PK exposures vs intravenous nivolumab in metastatic ccRCC.

Mexico
New-york
United-states
Saby-george
Jacobs-school-of-medicine
Network-clinical-trials
Roswell-park-comprehensive-cancer-center
University-of-buffalo
Biomedical-sciences
Jacobs-school
South-america
Nivolumab

vimarsana © 2020. All Rights Reserved.